Clinical Trials on Hepatosplenic T-cell Lymphoma
Total 6847 results
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Gray Zone Lymphoma | NK/T Cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
CStone PharmaceuticalsNot yet recruitingExtranodal NK/T-cell Lymphoma
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
Sun Yat-sen UniversityRecruiting
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-Hodgkin Lymphoma | NK/T Cell Lymphoma | Vascular Immunomother T Cell LymphomaChina
-
Bio-Path Holdings, Inc.RecruitingFollicular Lymphoma | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | DLBCL | Cutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)United States
-
Ou Bai, MD/PHDSecond Hospital of Jilin University; China-Japan Union Hospital, Jilin UniversityRecruitingAngioimmunoblastic T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedChina
-
Beijing Tongren HospitalRecruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced Solid Tumor | Cutaneous T-cell Lymphoma (CTCL)United States
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Active, not recruitingSenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaChina
-
Sun Yat-sen UniversityRecruitingPeripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeChina
-
Fudan UniversityUnknown
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic... and other conditionsUnited States
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of
-
OnxeoCompletedCutaneous T-cell LymphomaAustria, France, Germany, Switzerland
-
Navy General Hospital, BeijingChinese PLA General HospitalRecruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaChina
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterWithdrawnCutaneous T-cell Lymphoma
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownRelapsed or Refractory Peripheral T-cell and NK/T-cell LymphomaChina
-
Peking Union Medical College HospitalRecruitingPeripheral T Cell LymphomaChina
-
Ruijin HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsRecruiting
-
Ruijin HospitalRecruiting
-
Hospices Civils de LyonRecruitingPeripheral T Cell LymphomaFrance
-
Sun Yat-sen UniversityRecruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Solasia Pharma K.K.CompletedPeripheral T-Cell LymphomaHong Kong, Japan, Taiwan, Korea, Republic of
-
HUYABIO International, LLC.Quintiles, Inc.CompletedPeripheral T-Cell Lymphoma (PTCL)Japan, Korea, Republic of
-
University of BirminghamPfizer; BloodwiseCompletedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryUnited Kingdom
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedPeripheral T-Cell Lymphoma (PTCL)United States
-
Shandong New Time Pharmaceutical Co., LTDUnknownPeripheral T Cell Lymphoma
-
Beijing Tongren HospitalUnknown
-
Sun Yat-sen UniversityTerminatedLymphoma, Extranodal NK-T-CellChina
-
National Cancer Institute (NCI)Completed
-
Yuankai ShiUnknownPeripheral T Cell Lymphoma
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
McGill UniversityUnknownCutaneous T-Cell LymphomaCanada
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
University of Texas Southwestern Medical CenterWithdrawnCutaneous T-Cell LymphomasUnited States